BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 12955409)

  • 1. A randomized comparison of 4 doses of intracoronary adenosine in the assessment of fractional flow reserve.
    Casella G; Rieber J; Schiele TM; Stempfle HU; Siebert U; Leibig M; Theisen K; Buchmeier U; Klauss V
    Z Kardiol; 2003 Aug; 92(8):627-32. PubMed ID: 12955409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of incremental doses of intracoronary adenosine for fractional flow reserve assessment.
    Murtagh B; Higano S; Lennon R; Mathew V; Holmes DR; Lerman A
    Am Heart J; 2003 Jul; 146(1):99-105. PubMed ID: 12851614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are high doses of intracoronary adenosine an alternative to standard intravenous adenosine for the assessment of fractional flow reserve?
    Casella G; Leibig M; Schiele TM; Schrepf R; Seelig V; Stempfle HU; Erdin P; Rieber J; König A; Siebert U; Klauss V
    Am Heart J; 2004 Oct; 148(4):590-5. PubMed ID: 15459587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maximal hyperemia in the assessment of fractional flow reserve: intracoronary adenosine versus intracoronary sodium nitroprusside versus intravenous adenosine: the NASCI (Nitroprussiato versus Adenosina nelle Stenosi Coronariche Intermedie) study.
    Leone AM; Porto I; De Caterina AR; Basile E; Aurelio A; Gardi A; Russo D; Laezza D; Niccoli G; Burzotta F; Trani C; Mazzari MA; Mongiardo R; Rebuzzi AG; Crea F
    JACC Cardiovasc Interv; 2012 Apr; 5(4):402-8. PubMed ID: 22516396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of increasing doses of intracoronary adenosine on the assessment of fractional flow reserve.
    De Luca G; Venegoni L; Iorio S; Giuliani L; Marino P
    JACC Cardiovasc Interv; 2011 Oct; 4(10):1079-84. PubMed ID: 22017932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary hyperemic dose responses of intracoronary sodium nitroprusside.
    Parham WA; Bouhasin A; Ciaramita JP; Khoukaz S; Herrmann SC; Kern MJ
    Circulation; 2004 Mar; 109(10):1236-43. PubMed ID: 14993141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adequacy of intracoronary versus intravenous adenosine-induced maximal coronary hyperemia for fractional flow reserve measurements.
    Jeremias A; Whitbourn RJ; Filardo SD; Fitzgerald PJ; Cohen DJ; Tuzcu EM; Anderson WD; Abizaid AA; Mintz GS; Yeung AC; Kern MJ; Yock PG
    Am Heart J; 2000 Oct; 140(4):651-7. PubMed ID: 11011341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of efficacy and safety of intracoronary sodium nitroprusside and intravenous adenosine for assessing fractional flow reserve.
    Rudzinski W; Waller AH; Rusovici A; Dehnee A; Nasur A; Benz M; Sanchez S; Klapholz M; Kaluski E
    Catheter Cardiovasc Interv; 2013 Feb; 81(3):540-4. PubMed ID: 22961876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of increasing dose of intracoronary adenosine on peak hyperemia duration during fractional flow reserve assessment.
    Verdoia M; Erbetta R; Sagazio E; Barbieri L; Negro F; Suryapranata H; Kedhi E; De Luca G;
    Int J Cardiol; 2019 Jun; 284():16-21. PubMed ID: 30293665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of standard- and high-dose intracoronary adenosine for the measurement of coronary fractional flow reserve (FFR).
    Röther J; Achenbach S; Tröbs M; Blachutzik F; Nef H; Marwan M; Schlundt C
    Clin Res Cardiol; 2016 Dec; 105(12):1003-1010. PubMed ID: 27307094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of fractional flow reserve measurements using intracoronary adenosine versus intracoronary sodium nitroprusside infusions in moderately stenotic coronary artery lesions.
    Safi M; Namazi MH; Fooladi E; Vakili H; Parsa SA; Khaheshi I; Abbasi MA; Movahed MR
    Cardiovasc Revasc Med; 2016; 17(7):441-443. PubMed ID: 27432209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of the acute Pd/Pa drop after intracoronary nitroglycerin infusion to rule out significant FFR: CANICA (Can intracoronary nitroglycerin predict fractional flow reserve without adenosine?) multicenter study.
    Martin-Reyes R; de la Torre Hernandez JM; Franco-Pelaez J; Lopez-Palop R; Telleria Arrieta M; Amat Santos IJ; Carrillo Saez P; Sanchez-Recalde A; Sanmartin Pena JC; Garcia Camarero T; Brugaletta S; Gimeno de Carlos F; Pinero A; Sorto Sanchez DC; Frutos A; Lasa Larraya G; Navarro F; Farre J
    Catheter Cardiovasc Interv; 2016 Feb; 87(2):262-9. PubMed ID: 26213338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resting Pd/Pa and haemodynamic relevance of coronary stenosis as evaluated by fractional flow reserve.
    De Luca G; Verdoia M; Barbieri L; Marino P; Suryapranata H
    Coron Artery Dis; 2018 Mar; 29(2):138-144. PubMed ID: 29028737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of hyperemic efficacy between central and peripheral venous adenosine infusion for fractional flow reserve measurement.
    Seo MK; Koo BK; Kim JH; Shin DH; Yang HM; Park KW; Lee HY; Kang HJ; Kim HS; Oh BH; Park YB
    Circ Cardiovasc Interv; 2012 Jun; 5(3):401-5. PubMed ID: 22647519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of coronary fractional flow reserve measurements in guiding clinical decisions in intermediate or equivocal left main coronary stenoses.
    Courtis J; Rodés-Cabau J; Larose E; Potvin JM; Déry JP; Larochellière RD; Côté M; Cousterousse O; Nguyen CM; Proulx G; Rinfret S; Bertrand OF
    Am J Cardiol; 2009 Apr; 103(7):943-9. PubMed ID: 19327420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of regadenoson for measurement of fractional flow reserve.
    Prasad A; Zareh M; Doherty R; Gopal A; Vora H; Somma K; Mehra A; Clavijo LC; Matthews RV; Shavelle DM
    Catheter Cardiovasc Interv; 2014 Feb; 83(3):369-74. PubMed ID: 23765847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of contrast medium induced Pd/Pa ratio in predicting functional significance of intermediate coronary artery stenosis assessed by fractional flow reserve: insights from the RINASCI study.
    Leone AM; Scalone G; De Maria GL; Tagliaferro F; Gardi A; Clemente F; Basile E; Cialdella P; De Caterina AR; Porto I; Aurigemma C; Burzotta F; Niccoli G; Trani C; Rebuzzi AG; Crea F
    EuroIntervention; 2015 Aug; 11(4):421-7. PubMed ID: 25007836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracoronary and intravenous adenosine 5'-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans.
    De Bruyne B; Pijls NH; Barbato E; Bartunek J; Bech JW; Wijns W; Heyndrickx GR
    Circulation; 2003 Apr; 107(14):1877-83. PubMed ID: 12668522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pooled comparison of regadenoson versus adenosine for measuring fractional flow reserve and coronary flow in the catheterization laboratory.
    Stolker JM; Lim MJ; Shavelle DM; Morris DL; Angiolillo DJ; Guzman LA; Kennedy KF; Weber E; Zareh M; Neumayr RH; Zenni MM
    Cardiovasc Revasc Med; 2015; 16(5):266-71. PubMed ID: 26242981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of effectiveness of high-dose intracoronary adenosine versus intravenous administration on the assessment of fractional flow reserve in patients with coronary heart disease.
    López-Palop R; Carrillo P; Frutos A; Cordero A; Agudo P; Mashlab S; Bertomeu-Martínez V
    Am J Cardiol; 2013 May; 111(9):1277-83. PubMed ID: 23415635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.